VG

Vibha Gagan Sharma

Active Director Whole-Time Director DIN 02307289
DIN 02307289 First appointment Jul 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Jul 2008
Shareholding value •••• Premium profile

About Vibha Gagan Sharma

Data last updated:

Vibha Gagan Sharma is a Whole-Time Director at Bliss Gvs Pharma Limited (since 2008), Director at Kremoint Pharma Private Limited (since 2020) and Director at Eipii Exports Private Limited (since 2024), and holds 2 more current directorships. The companies operate in Pharma, Fashion and Textile and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹952 Cr; the largest is Bliss Gvs Pharma Limited at ₹846 Cr (FY 2025). Earlier, Vibha Gagan Sharma was an Additional Director at Plastic Ingenuities (I) Private Limited (2020–2023).

DIN 02307289
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 29 Jul 2008
Oldest Company Age 41 yrs
Largest company Bliss Gvs Pharma Limited · ₹846 Cr (FY 2025)
Combined revenue ₹952 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bliss Gvs Pharma Limited L24230MH1984PLC034771
Whole-Time Director29 Jul 20081984₹846 Cr (FY 2025)Active
Kremoint Pharma Private Limited U24230MH1992PTC066737
Director12 Jun 20201992₹64.72 Cr (FY 2025)Active
Eipii Exports Private Limited U52100MH2014PTC259675
Director20 Jul 20242014₹40.83 Cr (FY 2025)Active
Partner09 Feb 20232023Active
Gvsk Llp ABZ-7622
Designated Partner09 Jan 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Sep 20202014₹45 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aayushi Realtors Llp
Bliss Gvs Pharma Limited
Kremoint Pharma Private Limited
Gvsk Llp
Premium access

Shareholding and investment profile for Vibha Gagan Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vibha Gagan Sharma

Vibha Gagan Sharma currently holds 5 directorships: Bliss Gvs Pharma Limited (Whole-Time Director, since 29 Jul 2008, revenue ₹846 Cr (FY 2025)); Kremoint Pharma Private Limited (Director, since 12 Jun 2020, revenue ₹64.72 Cr (FY 2025)); Eipii Exports Private Limited (Director, since 20 Jul 2024, revenue ₹40.83 Cr (FY 2025)); Aayushi Realtors Llp (Partner, since 09 Feb 2023); Gvsk Llp (Designated Partner, since 09 Jan 2023).

Vibha Gagan Sharma was first appointed on 29 Jul 2008 as Whole-Time Director at Bliss Gvs Pharma Limited. The most recent appointment on record is 20 Jul 2024 at Eipii Exports Private Limited.

The 3 current companies of Vibha Gagan Sharma that report revenue have a combined latest revenue of ₹952 Cr: Bliss Gvs Pharma Limited ₹846 Cr (FY 2025); Kremoint Pharma Private Limited ₹64.72 Cr (FY 2025); Eipii Exports Private Limited ₹40.83 Cr (FY 2025).

Vibha Gagan Sharma held 1 earlier board appointment: Plastic Ingenuities (I) Private Limited (Additional Director, 22 Sep 2020 to 01 Jul 2023).

The current boards of Vibha Gagan Sharma's companies include Aditi Himanshu Bhatt (Bliss Gvs Pharma Limited), Deepak Bhalchandra Sawant (Bliss Gvs Pharma Limited), Nandkumar Kashinath Chodankar (Bliss Gvs Pharma Limited), Narsimha Shibroor Kamath (Bliss Gvs Pharma Limited), Santosh Laxman Parab (Bliss Gvs Pharma Limited), Shilpa Bhatia (Bliss Gvs Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available